Page 71 - 84_01
P. 71
senescence. Eur J Cancer. 2011; 47(11):1616-22. Sergio García Martínez et al.
10. Bosch-Presegué L, Vaquero A. The Dual role of Factor for Overall Survival in Colorectal Cancer
Sirtuins in Cancer. Genes Cancer. 2011; 2(6):648-62. Patients. Cell Physiol Biochem. 2016; 38(1):122-28.
11. Yao H, Rahman I. Perspectives on translational and 25. Wolkowitz OM, Mellon SH, Epel ES, Lin J, Dhabhar
therapeutic aspects of SIRT1 in inflammaging and FS, Su Y, Reus VI, Rosser R, Burke HM, Kupferman
senescence. Biochem Pharmacol. 2012; 84:1332-9. E, Compagnone M, Nelson JC, Blackburn EH.
Leukocyte telomere length in major depression:
12. Carafa V, Nebbioso A, Altucci L. Sirtuins and disease: correlations with chronicity, inflammation and
the roal ahead. Front Pharmacol. 2012; 3(4):1-6. oxidative stress--preliminary findings. PLoS One.
2011; 6(3):e17837.
13. Lakowa N, Trieu N, Flehmig G, Lohmann T, Schön
MR, Dietrich A, Zeplin PH, Langer S, Stumvoll M, 26. Sanz-Casla MT, Vidaurreta M, Sánchez-Rueda D,
Blüher M, Klöting N. Telomere length differences Maestro ML, Arroyo M, Cerdán FJ. Telomerase
between subcutaneous and visceral adipose tissue in activity as a prognostic factor in colorectal cancer.
humans. Biochem Biophys Res Commun. 2015; Onkologie. 2005; 28(11): 553-7.
457(3):426-32.
27. Fernández-Marcelo T, Morán A, de Juan C, Pascua I,
14. Blin N, Stafford DW. A general method for isolation Head J, Gómez A, Hernando F, López-Asenjo JA,
of high molecular weight DNA from eukaryotes. Hernández S, Sánchez-Pernaute A, Torres AJ, Benito
Nucleic Acids Res. 1976; 3(9):2303-8. M, Iniesta P. Differential expression of senescence
and cell death factors in non-small cell lung and
15. Pfaffl MW. A new mathematical model for relative colorectal tumors showing telomere attrition.
quantification in real-time RT-PCR. Nucleic Acids Oncology. 2012; 82(3):153-64.
Res. 2001; 29(9):2002-7.
28. Fernández-Marcelo T, Gómez A, Pascua I, de Juan C,
16. Kim NW, Piatyszek MA, Prowse KR, Harley CB, Head J, Hernando F, Jarabo JR, Calatayud J, Torres-
West MD, Ho PL, Coviello GM, Wright WE, García AJ, Iniesta P. Telomere length and telomerase
Weinrich SL, Shay JW. Specific association of human activity in non-small cell lung cancer prognosis:
telomerase activity with immortal cells and cancer. clinical usefulness of a specific telomere status. J Exp
Science. 1994; 266(5193):2011-15. Clin Cancer Res. 2015; 34(1):1-7.
17. Chomczynski P, Sacchi N. Single-step method of RNA 29. Kabra N, Li Z, Chen L, Li B, Zhang X, Wang C,
isolation by acid guanidinium thiocyanate-phenol- Yeatman T, Coppola D, Chen J. SirT1 is an inhibitor
chloroform extraction. Anal Biochem. 1987; 162 of proliferation and tumor formation in colon cancer. J
(1):156-9. Biol Chem. 2009; 284(27):18210-17.
18. Bertorelle R, Rampazzo E, Pucciarelli S, Nitti D, De 30. Grbesa I, Pajares MJ, Martínez-Terroba E, Agorreta J,
Rossi A. Telomeres, telomerase and colorectal cáncer. Mikecin AM, Larráyoz M, Idoate MA, Gall-Troselj K,
World J Gastroenterol. 2014; 20(8):1940-50. Pio R, Montuenga LM. Expression of sirtuin 1 and 2
is associated with poor prognosis in non-small cell
19. Fernández-Marcelo T, Sánchez-Pernaute A, Pascua I, lung cancer patients. PLoS One. 2015;
De Juan C, Head J, Torres-García AJ, Iniesta P. 10(4):e0124670.
Clinical relevance of telomere status and telomerase
activity in colorrectal cáncer. PLoS One. 2016; 31. Feng XX, Luo J, Liu M, Yan W, Zhou ZZ, Xia YJ, Tu
11(2):1-12. W, Li PY, Feng ZH, Tian DA. Sirtuin 6 promotes
transforming growth factor-ß1/H2O2/HOCl-mediated
20. García-Aranda C1, de Juan C, Díaz-López A, Sánchez- enhancement of hepatocellular carcinoma cell
Pernaute A, Torres AJ, Díaz-Rubio E, Balibrea JL, tumorigenicity by suppressing cellular senescence.
Benito M, Iniesta P. Correlations of telomere length, Cancer Sci. 2015; 106(5): 559-66.
telomerase activity, and telomeric-repeat binding
factor 1 expression in colorectal carcinoma. Cancer. 32. Sebastián C, Zwaans BM, Silberman DM, Gymrek M,
2006; 106(3). Goren A, Zhong L, Ram O, Truelove J, Guimaraes
AR, Toiber D, Cosentino C, Greenson JK, MacDonald
21. Haghighi MM, Aghagolzadeh P, Zadeh SM, Molaei AI, McGlynn L, Maxwell F, Edwards J, Giacosa S,
M, Zali MR, Radpour R. Telomere shortening: a Guccione E, Weissleder R, Bernstein BE, Regev A,
biological marker of sporadic colorectal cancer with Shiels PG, Lombard DB, Mostoslavsky R. The
normal expression of p53 and mismatch repair histone deacetylase SIRT6 is a tumor suppressor that
proteins. Genet Test Mol Biomarkers. 2014; controls cancer metabolism. Cell. 2012; 151(6):1185-
18(4):236-44. 9.
22. Feng TB, Cai LM, Qian KQ, Qi CJ. Reduced telomere 33. Lippitz BE. Cytokine patterns in patients with cancer:
length in colorectal carcinomas. Asian Pac J Cancer a systematic review. Lancet Oncol. 2013; 14(6):218-
Prev. 2012; 13(2):443-6. 28.
23. Zhao Z, Pan X, Liu L, Liu N. Telomere length 34. Blázquez-Martínez A, Chiesa M, Arnalich F,
maintenance, shortening, and lengthening. J Cell Fernández-Delgado J, Nistal M, De Miguel MP. c-Kit
Physiol. 2014; 229(10):1323-29. identifies a subpopulation of mesenchymal stem cells
24. Jia H, Wang Z. Telomere Length as a Prognostic @Real Academia Nacional de Farmacia. Spain
70
